Workshop on clinical investigation of new medicines for the treatment of multiple sclerosis takes place today
The European Medicines Agency's (EMA) workshop on the clinical investigation of new medicines for the treatment of multiple sclerosis is taking place at the Agency today from 8:30 to 18:20 London time.
You can follow a live broadcast of the workshop by clicking on the 'multimedia' tab on the event webpage. Summaries of the speakers' presentations are also available.
The EMA is organising this workshop following the public-consultation exercise on its revised guideline on clinical investigation of medicinal products for the treatment of multiple sclerosis .
The main goal of the workshop is to make sure that, while revising its guideline, the EMA can take account of the most up-to-date scientific developments in understanding and treating multiple sclerosis, as well as the positions of experts in the field on the main topics covered in the guideline.